With a risk of Down syndrome of 1 in 300 on the enhanced first‑trimester screen, what are the next steps?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Next Steps for Down Syndrome Risk of 1 in 300 on Enhanced First-Trimester Screen

Offer genetic counseling immediately, followed by the option of either cell-free DNA (cfDNA) testing as a secondary screen or proceeding directly to diagnostic testing with chorionic villus sampling (CVS) or amniocentesis, based on patient preference and gestational age. 1

Understanding Your Risk Level

A risk of 1 in 300 places you in what guidelines classify as a screen-positive result requiring prompt follow-up. However, it's critical to understand that this means you have approximately a 0.3% chance (99.7% chance of NOT having Down syndrome) that the fetus is affected 1. The vast majority of positive screens represent false positives—most commonly, an unaffected infant is the outcome 1.

Recommended Management Algorithm

Step 1: Genetic Counseling (Within 1 Working Day)

Screen-positive results should be transmitted promptly, typically by phone or fax, and genetic counseling should be arranged 1. This counseling should cover:

  • The meaning of your specific risk (1:300)
  • All available testing options with their risks and benefits
  • The fact that diagnostic testing remains the gold standard for definitive answers 2

Step 2: Choose Your Next Testing Option

Option A: Cell-free DNA (cfDNA) Testing - Secondary Screening

  • Advantages: Non-invasive, very high detection rate (>99% sensitivity and specificity for Down syndrome) 3, 4
  • Performance: If cfDNA is positive, the positive predictive value is 50-95%, meaning 1.1 to 2 diagnostic procedures needed to confirm each case 4
  • Limitations: Still a screening test, not diagnostic. Positive results require confirmation with amniocentesis 3, 4
  • No-call rate: Approximately 1% of samples fail to provide results, often due to low fetal fraction. Repeat testing provides results 75-80% of the time 4
  • Best for: Patients who want to refine their risk further before deciding on invasive testing

Option B: Diagnostic Testing - Definitive Answer

  • CVS (Chorionic Villus Sampling): Available now if you're between 10-13 weeks (some centers extend to 13 weeks 6 days) 1

    • Procedure-related loss risk: 1 in 300-600 (similar to your Down syndrome risk) 2
    • Transabdominal approach has lower loss rates than transcervical 2

  • Amniocentesis: Available starting at 15 weeks 1

    • Procedure-related loss risk: 1 in 300-600, with recent studies suggesting possibly no significant increase over background miscarriage risk 2

  • Best for: Patients who want a definitive answer and are comfortable with the small procedural risk

Option C: No Further Testing

  • This is a valid choice if you would not change pregnancy management regardless of results 2
  • You should not be required to undergo further testing if you don't want additional information 2

Important Considerations

Gestational Age Matters

Your current gestational age determines which diagnostic test is available:

  • Before 13 weeks 6 days: CVS is an option
  • 15 weeks onward: Amniocentesis becomes available
  • This timing may influence whether you choose cfDNA testing (which requires a new blood draw and time for results) versus proceeding directly to diagnostic testing

What Most Patients Do

Research shows that 93-97% of patients with risks in your range (1:51 to 1:270) do NOT proceed directly to invasive testing based on first-trimester results alone 5. Most either complete additional screening or opt for cfDNA testing to refine their risk further.

The Contingent/Reflex Model

Modern screening programs increasingly use your risk level to guide next steps 3:

  • High risk (>1:150): Offered direct diagnostic testing or cfDNA
  • Intermediate risk (1:150-1:800, which includes your 1:300): Typically offered cfDNA testing
  • Your risk of 1:300 falls into this intermediate category where cfDNA can be particularly useful

Critical Pitfalls to Avoid

  1. Don't assume a positive screen means the baby has Down syndrome: The positive predictive value at your risk level means most screen-positive results are false positives 1

  2. Understand that cfDNA is not diagnostic: Even with a positive cfDNA result, diagnostic testing is needed for confirmation before making irreversible decisions 3, 4

  3. Consider the procedure-related loss risk: At 1:300-600, the amniocentesis risk is similar to your Down syndrome risk, which is why many patients choose cfDNA first 2

  4. Don't delay unnecessarily: If you're approaching 14 weeks and want CVS, timing is critical. If you choose cfDNA, factor in the time needed for blood draw, processing, and potential need for repeat testing if initial sample fails 4

Other Findings to Discuss

Your screening also provides information about other chromosomal abnormalities including Trisomy 18 and 13 1. Genetic counseling should address these as well, though Down syndrome remains the primary focus of first-trimester screening 2.

References

Related Questions

What important assessments and screenings should be performed at the 12‑month well‑baby visit for a child with Down syndrome?
What are the common clinical features of Down syndrome?
What is the management for a 2-month-old baby with Down syndrome presenting with poor feeding, hepatosplenomegaly, murmur, and other symptoms?
A patient with suppressed TSH and elevated free T4 who has been taking methimazole 5 mg daily for one month—how should the methimazole dose be adjusted?
Can you briefly describe platelet function, specifically adhesion and aggregation, and explain the arachidonic acid pathway involved?
How does adding metolazone to an existing loop‑diuretic regimen improve respiratory congestion and shortness of breath caused by pulmonary fluid overload?
What is the significance and recommended management of a platelet count of 636 × 10⁹/L in a 15‑month‑old child with an otherwise normal complete blood count?
Do female-to-male transgender individuals require testosterone therapy for masculinization?
What is reverse triiodothyronine (rT3) and what is its clinical significance?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question